Author： Rufo Paul A. Bousvaros Athos
Publisher： Adis International
ISSN： 1174-5878
Source： Pediatric Drugs, Vol.8, Iss.5, 2006-01, pp. : 279-302
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Inflammatory Bowel Disease: Etiology, Pathogenesis and Current Therapy
Current Pharmaceutical Design, Vol. 20, Iss. 7, 2014-02 ,pp. :
Access to resources
Recommend
Infliximab Therapy in Children and Adolescents with Inflammatory Bowel Disease
By Veres Gabor
Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. :
Current pharmacotherapy for inflammatory bowel disease
Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 1, 1999-11 ,pp. :
Biologic Therapy for Inflammatory Bowel Disease
By Ardizzone Sandro Gabriele Bianchi Porro
Drugs, Vol. 65, Iss. 16, 2005-01 ,pp. :